M. Campone

Type de document

Articles (4)

Co-auteur

Date

Source

Mot-clé

cancer (4) Cancer (4) Patients (4) Cancer (4) Patients (4) survie (3) Treatment (3) Survival (3) administration (2) danger (2) procès (2) Methods (2) Ci (Chinese poetry) (2) State, The (2) Political science (2) Organization (2) Months (2) Management (2) Human beings (2) Evidence (2) Cycles (2) Confidence (2) Brain (2) Arm (2) Administrative law (2) Administration of estates (2) Administration (2) Methods (2) Administration (2) cerveau (2)

Documents écrit par M. Campone (4) | parle de M. Campone (0)

Oncological care organisation during COVID-19 outbreak.
C.E. Onesti et al.
Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082).
W. Wick et al. (1 oct. 2016)
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.
H. Bonnefoi et al. (2014)
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group.
R. Stupp et al. (2011)